绝经后及老年性骨质疏松症的发病机制与治疗研究 - Suppr

Suppr

超能文献

Studies on pathogenesis and treatment in postmenopausal and senile osteoporosis.

作者信息

Riggs B L, Jowsey J, Kelly P J, Hoffman D L, Arnaud C D

出版信息

Clin Endocrinol Metab. 1973 Jul;2(2):317-32. doi: 10.1016/s0300-595x(73)80046-5.

DOI:10.1016/s0300-595x(73)80046-5

PMID:4373194

Abstract

摘要

相似文献

Studies on pathogenesis and treatment in postmenopausal and senile osteoporosis.

Clin Endocrinol Metab. 1973 Jul;2(2):317-32. doi: 10.1016/s0300-595x(73)80046-5.

Bone turnover-sex hormone-parathyroid hormone interrelationships in postmenopausal osteoporosis.

Boll Soc Ital Biol Sper. 1973 Jul 30;49(12):732-7.

Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis.

J Clin Invest. 1972 Jul;51(7):1659-63. doi: 10.1172/JCI106967.

Drugs for postmenopausal osteoporosis.

Med Lett Drugs Ther. 1980 May 30;22(11):45-6.

Postmenopausal and senile osteoporosis: current concepts of etiology and treatment.

Endocrinol Jpn. 1979 Jun;26(Suppl):31-41. doi: 10.1507/endocrj1954.26.supplement_31.

New concepts in the treatment of osteoporosis.

Postgrad Med. 1972 Oct;52(4):62-7. doi: 10.1080/00325481.1972.11713258.

Antifracture efficacy of long-term estrogens for osteoporosis.

Trans Assoc Am Physicians. 1973;86:326-32.

Osteoporosis, or the osteoporosities?

Am J Med Sci. 1968 Nov;256(5):271-8. doi: 10.1097/00000441-196811000-00001.

Metabolic bone disease--recent developments.

S Afr Med J. 1974 Feb;48(9):350-2.

Postmenopausal osteoporosis.

Am Fam Physician. 1973 Dec;8(6):74-83.

引用本文的文献

Inhibitory effect of Astragalus Membranaceus on osteoporosis in SAMP6 mice by regulating vitaminD/FGF23/Klotho signaling pathway.

Bioengineered. 2021 Dec;12(1):4464-4474. doi: 10.1080/21655979.2021.1946633.

Fluoride for treating postmenopausal osteoporosis.

Cochrane Database Syst Rev. 2000;2000(4):CD002825. doi: 10.1002/14651858.CD002825.

Effects of oral supplementation with stable strontium.

Can Med Assoc J. 1981 Oct 1;125(7):703-12.

The hormonal form of vitamin D in the pathophysiology and therapy of postmenopausal osteoporosis.

J Endocrinol Invest. 1984 Aug;7(4):373-8. doi: 10.1007/BF03351019.

Fluoride treatment in corticosteroid induced osteoporosis.

Arch Dis Child. 1986 Dec;61(12):1230-1. doi: 10.1136/adc.61.12.1230.

Factors affecting the hypocalcaemic response to protamine.

Acta Vet Scand. 1975;16(1):51-62. doi: 10.1186/BF03546695.

Endogenous oestrogen and bone loss following oophorectomy.

Calcif Tissue Res. 1977 May;22 Suppl:213-6. doi: 10.1007/BF02064067.

Treatment of osteoporosis.

Br Med J. 1978 May 20;1(6123):1303-4.

Treatment of postmenopausal osteoporosis.

Drugs. 1979 Dec;18(6):484-92. doi: 10.2165/00003495-197918060-00004.

Bone and ageing.

Ann Rheum Dis. 1975 Feb;34(1):100-15. doi: 10.1136/ard.34.1.100.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Studies on pathogenesis and treatment in postmenopausal and senile osteoporosis.

Clin Endocrinol Metab. 1973 Jul;2(2):317-32. doi: 10.1016/s0300-595x(73)80046-5.

Bone turnover-sex hormone-parathyroid hormone interrelationships in postmenopausal osteoporosis.

Boll Soc Ital Biol Sper. 1973 Jul 30;49(12):732-7.

Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis.

J Clin Invest. 1972 Jul;51(7):1659-63. doi: 10.1172/JCI106967.

Drugs for postmenopausal osteoporosis.

Med Lett Drugs Ther. 1980 May 30;22(11):45-6.

Postmenopausal and senile osteoporosis: current concepts of etiology and treatment.

Endocrinol Jpn. 1979 Jun;26(Suppl):31-41. doi: 10.1507/endocrj1954.26.supplement_31.

New concepts in the treatment of osteoporosis.

Postgrad Med. 1972 Oct;52(4):62-7. doi: 10.1080/00325481.1972.11713258.

Antifracture efficacy of long-term estrogens for osteoporosis.

Trans Assoc Am Physicians. 1973;86:326-32.

Osteoporosis, or the osteoporosities?

Am J Med Sci. 1968 Nov;256(5):271-8. doi: 10.1097/00000441-196811000-00001.

Metabolic bone disease--recent developments.

S Afr Med J. 1974 Feb;48(9):350-2.

Postmenopausal osteoporosis.

Am Fam Physician. 1973 Dec;8(6):74-83.

引用本文的文献

Inhibitory effect of Astragalus Membranaceus on osteoporosis in SAMP6 mice by regulating vitaminD/FGF23/Klotho signaling pathway.

Bioengineered. 2021 Dec;12(1):4464-4474. doi: 10.1080/21655979.2021.1946633.

Fluoride for treating postmenopausal osteoporosis.

Cochrane Database Syst Rev. 2000;2000(4):CD002825. doi: 10.1002/14651858.CD002825.

Effects of oral supplementation with stable strontium.

Can Med Assoc J. 1981 Oct 1;125(7):703-12.

The hormonal form of vitamin D in the pathophysiology and therapy of postmenopausal osteoporosis.

J Endocrinol Invest. 1984 Aug;7(4):373-8. doi: 10.1007/BF03351019.

Fluoride treatment in corticosteroid induced osteoporosis.

Arch Dis Child. 1986 Dec;61(12):1230-1. doi: 10.1136/adc.61.12.1230.

Factors affecting the hypocalcaemic response to protamine.

Acta Vet Scand. 1975;16(1):51-62. doi: 10.1186/BF03546695.

Endogenous oestrogen and bone loss following oophorectomy.

Calcif Tissue Res. 1977 May;22 Suppl:213-6. doi: 10.1007/BF02064067.

Treatment of osteoporosis.

Br Med J. 1978 May 20;1(6123):1303-4.

Treatment of postmenopausal osteoporosis.

Drugs. 1979 Dec;18(6):484-92. doi: 10.2165/00003495-197918060-00004.

Bone and ageing.

Ann Rheum Dis. 1975 Feb;34(1):100-15. doi: 10.1136/ard.34.1.100.